Human medicines European public assessment report (EPAR): Rolcya, denosumab, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 27 November 2025 - 15:35

Human medicines European public assessment report (EPAR): Rolcya, denosumab, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Jubbonti, denosumab, Date of authorisation: 16/05/2024, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 27 November 2025 - 15:32

Human medicines European public assessment report (EPAR): Jubbonti, denosumab, Date of authorisation: 16/05/2024, Revision: 3, Status: Authorised

14th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 09:00 (CEST) to 30 September 2025, 13:15 (CEST)

Submitted by Anonymous (not verified) on 27 November 2025 - 15:31

14th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 09:00 (CEST) to 30 September 2025, 13:15 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness